Fmoc-L-Propargylglycine,
198561-07-8,
Fmoc-Pra-OH,
(S)-2-(Fmoc-amino)-4-pentynoic acid,
Fmoc-propargyl-Gly-OH,
MFCD01075095,
(S)-N-Fmoc-2-(2'-propynyl)glycine,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)pent-4-ynoic acid,
4-Pentynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-,
J-300362,
Fmoc-Propargyl-Gly-OH;(S)-2-(Fmoc-amino)-4-pentynoic acid,
(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-ynoic acid,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pent-4-ynoic acid,
4-Pentynoicacid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-,
AK170049,
Fmoc-L-Pra-OH,
Fmoc-Gly(propargyl)-OH,
N-Fmoc-L-propargylglycine,
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-propargylglycine,
AC1MC16U,
Fmoc-alpha-Propargyl-Gly-OH,
Fmoc-(S)-2-Propargylglycine,
SCHEMBL119866,
CTK0H4118,
DTXSID80370319,
DJGMNCKHNMRKFM-SFHVURJKSA-N,
ZINC2572518,
ZX-AT014710,
CF-385,
AKOS015948708,
AC-9949,
ACN-044473,
AM82637,
CS-W011926,
FCH2715084,
FL378-1,
GS-6245,
OR14676,
RTR-009239,
(S)-N-Fmoc-2-(2'-pro pynyl)glycine,
KS-00000J29,
AN-30088,
M503,
AB0015249,
TL8006256,
TR-009239,
F0926,
Fmoc-propargyl-Gly-OH, >=98.0% (HPLC),
FT-0657924,
M-1163,
561F078,
(2S)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-pentynoic acid,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)pent-4-ynoic acid,
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pent-4-ynoic acid,
(2S)-2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]-4-pentynoic acid,
C20H17NO4,
CID2734461,
2-(9H-fluoren-9-ylmethoxycarbonylamino)pent-4-ynoic Acid,